BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 18697945)

  • 1. Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage.
    Berman SD; Calo E; Landman AS; Danielian PS; Miller ES; West JC; Fonhoue BD; Caron A; Bronson R; Bouxsein ML; Mukherjee S; Lees JA
    Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11851-6. PubMed ID: 18697945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of osteoblastic differentiation on osteosarcomagenesis in the mouse.
    Quist T; Jin H; Zhu JF; Smith-Fry K; Capecchi MR; Jones KB
    Oncogene; 2015 Aug; 34(32):4278-84. PubMed ID: 25347737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling.
    Lengner CJ; Steinman HA; Gagnon J; Smith TW; Henderson JE; Kream BE; Stein GS; Lian JB; Jones SN
    J Cell Biol; 2006 Mar; 172(6):909-21. PubMed ID: 16533949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Osteosarcomas from a Combination of Rb Silencing and c-Myc Overexpression in Human Mesenchymal Stem Cells.
    Wang JY; Wu PK; Chen PC; Lee CW; Chen WM; Hung SC
    Stem Cells Transl Med; 2017 Feb; 6(2):512-526. PubMed ID: 28191765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTORC1 maintains the tumorigenicity of SSEA-4(+) high-grade osteosarcoma.
    Zhang W; Ding ML; Zhang JN; Qiu JR; Shen YH; Ding XY; Deng LF; Zhang WB; Zhu J
    Sci Rep; 2015 Apr; 5():9604. PubMed ID: 25853231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development.
    Rubio R; Gutierrez-Aranda I; Sáez-Castillo AI; Labarga A; Rosu-Myles M; Gonzalez-Garcia S; Toribio ML; Menendez P; Rodriguez R
    Oncogene; 2013 Oct; 32(41):4970-80. PubMed ID: 23222711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1).
    Pereira BP; Zhou Y; Gupta A; Leong DT; Aung KZ; Ling L; Pho RW; Galindo M; Salto-Tellez M; Stein GS; Cool SM; van Wijnen AJ; Nathan SS
    J Cell Physiol; 2009 Dec; 221(3):778-88. PubMed ID: 19746444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.
    Rubio R; Abarrategi A; Garcia-Castro J; Martinez-Cruzado L; Suarez C; Tornin J; Santos L; Astudillo A; Colmenero I; Mulero F; Rosu-Myles M; Menendez P; Rodriguez R
    Stem Cells; 2014 May; 32(5):1136-48. PubMed ID: 24446210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas.
    Basu-Roy U; Seo E; Ramanathapuram L; Rapp TB; Perry JA; Orkin SH; Mansukhani A; Basilico C
    Oncogene; 2012 May; 31(18):2270-82. PubMed ID: 21927024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors.
    Dani N; Olivero M; Mareschi K; van Duist MM; Miretti S; Cuvertino S; Patané S; Calogero R; Ferracini R; Scotlandi K; Fagioli F; Di Renzo MF
    J Bone Miner Res; 2012 Jun; 27(6):1322-34. PubMed ID: 22367914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RANKL blockade prevents and treats aggressive osteosarcomas.
    Chen Y; Di Grappa MA; Molyneux SD; McKee TD; Waterhouse P; Penninger JM; Khokha R
    Sci Transl Med; 2015 Dec; 7(317):317ra197. PubMed ID: 26659571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local mesenchymal stem/progenitor cells are a preferential target for initiation of adult soft tissue sarcomas associated with p53 and Rb deficiency.
    Choi J; Curtis SJ; Roy DM; Flesken-Nikitin A; Nikitin AY
    Am J Pathol; 2010 Nov; 177(5):2645-58. PubMed ID: 20864684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The retinoblastoma protein in osteoblast differentiation and osteosarcoma.
    Deshpande A; Hinds PW
    Curr Mol Med; 2006 Nov; 6(7):809-17. PubMed ID: 17100605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling distinct osteosarcoma subtypes in vivo using Cre:lox and lineage-restricted transgenic shRNA.
    Mutsaers AJ; Ng AJ; Baker EK; Russell MR; Chalk AM; Wall M; Liddicoat BJ; Ho PW; Slavin JL; Goradia A; Martin TJ; Purton LE; Dickins RA; Walkley CR
    Bone; 2013 Jul; 55(1):166-78. PubMed ID: 23486187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXP1 drives osteosarcoma development by repressing P21 and RB transcription downstream of P53.
    Li H; Han X; Yang S; Wang Y; Dong Y; Tang T
    Oncogene; 2021 Apr; 40(15):2785-2802. PubMed ID: 33716296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of Runx2 as a key parameter in the etiology of osteosarcoma.
    Nathan SS; Pereira BP; Zhou YF; Gupta A; Dombrowski C; Soong R; Pho RW; Stein GS; Salto-Tellez M; Cool SM; van Wijnen AJ
    Mol Biol Rep; 2009 Jan; 36(1):153-8. PubMed ID: 18931939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoblast-specific inactivation of p53 results in locally increased bone formation.
    Liao N; Koehne T; Tuckermann J; Triviai I; Amling M; David JP; Schinke T; Luther J
    PLoS One; 2021; 16(11):e0249894. PubMed ID: 34793446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease.
    Walkley CR; Qudsi R; Sankaran VG; Perry JA; Gostissa M; Roth SI; Rodda SJ; Snay E; Dunning P; Fahey FH; Alt FW; McMahon AP; Orkin SH
    Genes Dev; 2008 Jun; 22(12):1662-76. PubMed ID: 18559481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of the tumorigenic potential of human retinoblastoma cell lines by TFF1 overexpression involves p53/caspase signaling and miR-18a regulation.
    Busch M; Große-Kreul J; Wirtz JJ; Beier M; Stephan H; Royer-Pokora B; Metz K; Dünker N
    Int J Cancer; 2017 Aug; 141(3):549-560. PubMed ID: 28481041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma.
    Thomas DM; Johnson SA; Sims NA; Trivett MK; Slavin JL; Rubin BP; Waring P; McArthur GA; Walkley CR; Holloway AJ; Diyagama D; Grim JE; Clurman BE; Bowtell DD; Lee JS; Gutierrez GM; Piscopo DM; Carty SA; Hinds PW
    J Cell Biol; 2004 Dec; 167(5):925-34. PubMed ID: 15583032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.